Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,068,000 | 1,878,000 | 1,774,000 | 1,196,000 | 1,332,000 |
| Marketable Securities | 13,437,000 | 10,673,000 | 10,770,000 | 10,140,000 | 8,561,000 |
| Receivables | 10,960,000 | 5,785,000 | 6,099,000 | 6,273,000 | 6,453,000 |
| Inventories | 2,599,000 | 2,678,000 | 2,909,000 | 2,805,000 | 2,750,000 |
| Other current assets | 287,000 | 1,970,000 | 397,000 | 274,000 | 250,000 |
| TOTAL | $31,103,000 | $24,781,000 | $23,670,000 | $22,386,000 | $20,970,000 |
| Non-Current Assets | |||||
| PPE Net | 11,038,000 | 10,712,000 | 11,076,000 | 10,784,000 | 10,496,000 |
| Investments And Advances | 5,139,000 | 5,161,000 | 5,110,000 | 5,118,000 | 5,304,000 |
| Intangibles | 1,230,000 | 2,121,000 | 1,304,000 | 1,288,000 | 1,824,000 |
| Other Non-Current Assets | 4,418,000 | 3,581,000 | 3,716,000 | 2,992,000 | 2,722,000 |
| TOTAL | $21,825,000 | $21,575,000 | $21,206,000 | $20,182,000 | $20,346,000 |
| Total Assets | $52,928,000 | $46,356,000 | $44,876,000 | $42,568,000 | $41,316,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,265,000 | 8,669,000 | 10,690,000 | 8,366,000 | 7,746,000 |
| Accounts payable and accrued liabilities | 1,374,000 | 1,620,000 | 1,551,000 | 1,524,000 | 1,591,000 |
| Accrued Expenses | 947,000 | 1,084,000 | 1,004,000 | 916,000 | 915,000 |
| Other current liabilities | 3,635,000 | 3,448,000 | 3,280,000 | 3,141,000 | 3,102,000 |
| TOTAL | $18,754,000 | $18,555,000 | $18,401,000 | $16,317,000 | $14,729,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,713,000 | 3,140,000 | 3,118,000 | 3,072,000 | 2,580,000 |
| Other Non-Current Liabilities | 4,432,000 | 4,347,000 | 3,994,000 | 3,994,000 | 3,957,000 |
| TOTAL | $9,331,000 | $7,851,000 | $7,522,000 | $7,421,000 | $6,913,000 |
| Total Liabilities | $28,085,000 | $26,406,000 | $25,923,000 | $23,738,000 | $21,642,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,894,470 | 6,158,348 | 6,162,164 | 6,189,667 | 6,244,712 |
| Common Shares | 342,000 | 341,000 | 341,000 | 340,000 | 340,000 |
| Retained earnings | 34,908,000 | 30,243,000 | 29,099,000 | 26,742,000 | 26,788,000 |
| Other shareholders' equity | -2,935,000 | -3,661,000 | -3,335,000 | -3,985,000 | -4,204,000 |
| TOTAL | $24,843,000 | $19,950,000 | $18,953,000 | $18,830,000 | $19,674,000 |
| Total Liabilities And Equity | $52,928,000 | $46,356,000 | $44,876,000 | $42,568,000 | $41,316,000 |